Current Assets Endring Dato
Abbott USD 23.51B 872M 2023-06
Amgen USD 30.33B 18.14B 2023-12
Biogen USD 6.86B 1.59B 2023-12
Cara Therapeutics USD 100.6M 24.13M 2023-09
Cassava Sciences USD 150.18M 24.35M 2023-09
Eisai JPY 659.27B 19.2B 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Geron USD 341.35M 6.26M 2023-12
J&J USD 53.7B 6.86B 2023-09
Merck USD 31.95B 1.98B 2023-09
Novavax USD 1.01B 120.79M 2023-09
Pfizer USD 74.01B 665M 2023-09
Roche Holding CHF 30.98B 2.84B 2023-06



Cassava Sciences Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.